TD Asset Management »

Allogene Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $764k 238k 3.21
2023-09-30 $754k 238k 3.17
2023-06-30 $991k 200k 4.97
2023-03-31 $858k 174k 4.94
2022-12-31 $1.1M 174k 6.29
2022-09-30 $1.7M 165k 10.32
2022-06-30 $1.5M 128k 11.40
2022-03-31 $1.1M 122k 9.11
2021-12-31 $1.6M 109k 14.92
2021-09-30 $2.9M 111k 25.70
2021-06-30 $2.0M 92k 21.95
2021-03-31 $2.9M 82k 35.30
2020-12-31 $2.0M 78k 25.25
2020-09-30 $2.9M 78k 37.71
2020-06-30 $3.5M 83k 42.82
2020-03-31 $1.1M 54k 19.44
2019-12-31 $1.5M 58k 25.99
2019-09-30 $1.6M 58k 27.25
2019-06-30 $1.6M 58k 26.85
2019-03-31 $741k 26k 28.90
2018-12-31 $674k 25k 26.91